Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Fetal and Maternal Sufentanil Pharmacokinetics After Intra-amniotic Injection

NCT02962830 is registered in ClinicalTrials.gov with University Hospital, Lille as lead sponsor.

NCT NCT02962830
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02962830 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Fetal and Maternal Sufentanil Pharmacokinetics After Intra-amniotic Injection
Lead sponsor
University Hospital, Lille
Phase
Phase 2
Overall status
Completed
Start date
April 19, 2017
Completion date
May 29, 2024
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prenatal diagnosis